14_references 8.pdf - shodhganga

CHAPTER 8 REFERENCES

REFERENCES

SPTM SVKMrsquoS NMIMS MUMBAI 259

1 Y Kwon Handbook of essential pharmacokinetics pharmacodynamics and

drug metabolism for industrial scientists 2001 Springer publication New

York PP 35-45

2 L Edwards et al Principle and practice of pharmaceutical medicines 2 nd

edition2007 Wiley publication PP 85

3 W Foye et al Foyersquos Principles of medicinal chemistry sixth edition2007

Lippincott publication PP 300

4 C Ehrhardt et al Drug absorption studies in situ in vitro and in silico models

illustrated edition AAPS Press Springer publication 2008 PP 666

5 Y Qiu et al Developing solid oral dosage formspharmaceutical theory and

practice first edition 2009 Elsvier Publication USA PP 421-436

6 A Avdeef Absorption and drug development solubilitypermeability and

charge state John Wiley and sons Wiley interscience publication 2003 PP

20

7 Waiver of in vivo bioavailability and bioequivalence studies for immediate

release solid oral dosage forms based on a biopharmaceutics classification

system Guidance for industry USFDACDER Aug 2000

8 httpenwikipediaorgwikiBioavailability

9 Wagh et al Biopharmaceutical classification system International journal of

pharmacy and pharmaceutical sciences 2(1) 2010 PP 12-19

10 Banker and Rhodes Modern pharmaceutics 121 fourth edition Marcel

Dekker PP 84-86

11 Brahmankar and Jaiswal et al Biopharmaceutics and pharmacokinetics- a

treatise first edition Vallabh prakashan Delhi PP 18

REFERENCES


12 httpwwwboomerorgcp3c22c2201html

13 Touitou and Barry Enhancement in drug delivery CRC press Taylor and

francis group 2006 PP 112

14 B Hancock et al Characteristics and significance of the amorphous state in

pharmaceutical systems Journal Pharmaceutical Sciences 86 1997 PP 1ndash12

15 M Grau et al Nanosuspensions of poorly soluble drugs ndash reproducibility of

small scale production Inetrnational Journal of Pharmaceutics 196 2000 PP

155ndash157

16 G Liversidge et al Particle size reduction for improvement of oral

bioavailability of hydrophobic drugs absolute oral bioavailability of

nanocrystalline danazol in beagle dogs Inetrnational Journal of

Pharmaceutics 125 1995 PP 91ndash97

17 J Hargrove et al Absorption of oral progesterone is influenced by vehicle and

particle size American Journal of Obstetrics and Gynecology 161 1989 PP

948ndash951

18 A Jounela et al Effect of particle size on the bioavailability of digoxin

European Journal of clinical Pharmacology 8 1975 PP 365ndash370

19 Y Ran et al Solubilization and Preformulation Studies on PG-300995 (an

anti-HIV drug) Journal of Pharmaceutical Sciences 94 (2) 2005 PP 297ndash

303

20 C Mbah Solubilization of valsartan by aqueous glycerol polyethylene glycol

and micellar solutions Pharmazie 61 (4) 2006 PP 322-324

21 R Chang et al Effect of Hydroxypropyl Beta-Cyclodextrin on Drug

Solubility in Water-Propylene Glycol Mixtures Drug Development and

Industrial Pharmacy 30 (3) 2004 PP 297ndash302

REFERENCES


22 S Han et al Solubilization of Biphenyl Dimethyl Dicarboxylate by

Cosolvency Drug Development and Industrial Pharmacy 25 (11) 1999 PP

1193ndash1197

23 R Stancanelli et al The enhancement of isoflavones water solubility by

complexation with modified cyclodextrins A spectroscopic investigation with

implications in the pharmaceutical analysis Journal of Pharmaceutical and

biomedical analysis 44 (4) 2007 PP 980-984

24 S Gibaud et al Melarsoprolndashcyclodextrins inclusion complexes International

Journal of Pharmaceutics 306 ( 1-2) 2005 PP 107-121

25 S Wong et al Enhancement of the dissolution rate and oral absorption of a

poorly water soluble drug by formation of surfactant-containing

microparticles International Journal of Pharmaceutics 317 (1) 2006 PP 61-

68

26 Ryh-Nan Pan et al Enhancement of Dissolution and Bioavailability of

Piroxicam in Solid Dispersion Systems Drug Development and Industrial

Pharmacy 26 (9) 2000 PP 989 ndash 994

27 H Joshi et al Bioavailability enhancement of a poorly water-soluble drug by

solid dispersion in polyethylene glycolndash polysorbate 80 mixture International

Journal of Pharmaceutics 269 (1) 2004 PP 251-258

28 R Muller et al Emulsions and nanosuspensions for the formulation of poorly

soluble drugs Medpharm Scientific Publishers Stuttgart Germany 1998 PP

149ndash174

29 R Muller et al Nanosuspensions as Particulate Drug Formulations in

Therapy Rationale for Development and What We Can Expect for the Future

Advances in Drug Delivery Reviews 47 (1) 2001 PP 3ndash19

REFERENCES


30 E Liversidge et al Nanosizing A Formulation Approach for Poorly Water-

Soluble Compounds European Journal of Pharmaceutical Sciences 18 (2)

2003 PP 113ndash120

31 P Lockman et al Nanoparticle Technology for Drug Delivery Across the

Blood-Brain Barrier Drug Development and Industrial Pharmacy 28 (1)

2002 PP 1ndash13

32 B Rabinow Nanosuspensions in Drug Delivery Nature Reviews Drug

discovery 3 (9) 2004 PP 785ndash796

33 V Patravale et al Nanosuspensions A Promising Drug Delivery Strategy

Journal of Pharmacy and Pharmacology 56 (7) 2004 PP 827ndash840

34 G Liversidge et al Particle Size Reduction for Improvement of Oral

Bioavailability of Hydrophobic Drugs I Absolute Oral Bioavailability of

Nanocrystalline Danazol in Beagle Dogs International Journal of

Pharmaceutics 125 (1)1995 PP 91ndash97

35 J Hecq et al Preparation and Characterization of Nanocrystals for Solubility

and Dissolution Rate Enhancement of Nifedipine International Journal of

Pharmaceutics 299 (1ndash2) 2005 PP 167ndash177

36 E Reverchon et al Production of Antibiotic Micro- and Nano-Particles by

Supercritical Antisolvent Precipitation Powder Technology 106 (1ndash2) 1999

PP 23ndash29

37 P Chattopadhyay et al Protein Nanoparticles Formation by Supercritical

Antisolvent with Enhanced Mass Transfer AIChE Journal 48 2002 PP

235ndash244

38 T Young et al Rapid Expansion from Supercritical to Aqueous Solution to

Produce Submicron Suspensions of Water-Insoluble Drugs Biotechnology

Progress 16 (3) 2000 PP 402ndash407

REFERENCES


39 J Hu et al Rapid Dissolving High Potency Danazol Powders Produced by

Spray Freezing into Liquid Process International Journal of Pharmaceutics

271 (1ndash2) 2004 PP 145ndash154

40 J Hu et al Stable Amorphous Danazol Nanostructured Powders with Rapid

Dissolution Rates Produced by Spray Freezing into Liquid Drug Development

and Industrial Pharmacy 30 (7) 2004 PP 695ndash704

41 X Chen et al Rapid Dissolution of High Potency Danazol Powders Produced

by Evaporative Precipitation into Aqueous Solution Journal of

Pharmaceutical Sciences 93 (7) 2004 PP 1867ndash1878

42 JVaughn et al Supersaturation produces high bioavailability of amorphous

danazol particles formed by evaporative precipitation into aqueous solution

and spray freezing into liquid technologies Drug Development and Industrial

Pharmacy 32(5) 2006 PP 559-567

43 XChen et al Preparation of cyclosporine A nanoparticles by evaporative

precipitation into aqueous solution International Journal of Pharmaceutics

242 (1-2) 2002 PP 3-14

44 V Hoffarta et al Oral bioavailability of a low molecular weight heparin using

a polymeric delivery system Journal of Controlled Release 113 (1) 2006

PP 38-42

45 MGonzalez et al Nanoencapsulation of acetyl salicylic acid within enteric

polymer nanoparticles Reviews on Advanced Materials Science17 2008 PP

71-75

46 CPinto Reis et al Nanoencapsulation I Methods for preparation of drug

loaded polymeric nanoparticles Nanomedicine 2 2006 PP 8-21

47 TP Shakhtshneider et al The mechanochemical preparation of solid disperse

systems of ibuprofenndashpolyethylene glycol International Journal of

Pharmaceutics1301996 PP 25ndash32

REFERENCES


48 M Sugimoto et al Improvement of dissolution characteristics and

bioavailability of poorly water-soluble drugs by novel cogrinding method

using water soluble-polymer International Journal of Pharmaceutics 160

1998 PP 11ndash19

49 M Vogt et al Cogrinding enhances the oral bioavailability of EMD 57033 a

poorly water soluble drug in dogs European Journal of Pharmaceutics and

Biopharmaceutics 68 (2) 2008 PP 338-345

50 C Pouton et al Formulation of self-emulsifying drug delivery systems

Advanced Drug Delivery Reviews 25 (1) 1997 PP 47-58

51 W Wu et al Enhanced bioavailability of silymarin by self-microemulsifying

drug delivery system European Journal of Pharmaceutics and


52 S Kapsi et al Processing factors in development of solid solution formulation

of itraconazole for enhancement of drug dissolution and bioavailability

International Journal of Pharmaceutics229 2001 PP 193ndash203

53 B Katzung et al Basic and clinical Pharmacology 11th

edition 2009

McGraw Hill Publication PP 167-188

54 FBarar Antihypertensive drugs Essentials of Pharmacotherapeutics 5th

edition 2009 SChand and Company Ltd PP 239-249

55 httpwwwrxlistcomdrugsalpha_ahtm

56 Atacand Product monograph Astrazeneca Canada 2008

57 H Matsunaga et al Solid state characterization of candesartan cilexetil (TCV

116) crystal structure and molecular mobilityChemical and Pharmaceutical

Bulletine 47(2) 1999 PP 182-186

58 httpwwwespacenetcomindexenhtm

REFERENCES


59 httpwwwpatentlensnetdaisypatentlenspatentlenshtml

60 httpwwwsciruscom

61 United States pharmacopeia 32 NF 272009

62 DSubba Rao et al A stability indicating LC method for candesartan cilexetil

Chromatographia 66 (7-8) 2007 PP 499-507

63 SQutab et al Simple and sensitive LC-UV method for simultaneous analysis

of hydrochlorothiazide and candesartan cilexetil in pharmaceutical

formulations Acta Chromatographica 19 2007 PP 119-129

64 LZhang et al HPLC-UV simultaneous determination of candesartan cilexetil

and hydrochlorothiazide in compound candesartan cilexetil tablets Chienese

journal of Pharmaceutical Analysis 27 (4) 2007 PP 566-568

65 DDuchene et al Pharmaceutical uses of cyclodextrins and derivatives Drug

development and industrial pharmacy161990 PP 2487-2499

66 T Loftsson et al Pharmaceutical applications of cyclodextrinsdrug

solubilization and stabilization Journal of pharmaceutical sciences851996PP

1017-1025

67 RO Williams et al Characterization of an inclusion complex of cholesterol

and hydroxypropyl-β-Cyclodextrin European journal of pharmaceutics and

biopharmaceutics461998PP 355-360

68 JSzejtli Pastpresent and future of cyclodextrin research Pure and applied

chemistry 76(10)2004 PP 1825-1845

69 SBaboota et alCyclodextrins in drug delivery systems An update Latest

reviews 12003 retrieved from pharmainfonet

70 Innovative drug delivery technology for enhanced solubility and

stabilityCyDexIncOct 2004

REFERENCES


71 GBettinetti et alInteraction of naproxen with noncrystalline acetyl beta and

acetyl gamma cyclodextrins in the solid and liquid stateEuropean Journal of

Pharmaceutical Sciences152002PP 21-29

72 CGazpio et al HPLC and solubility study of the interaction between pindolol

and cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis37

2005PP 487-492

73 AMiro et alImprovement of gliquidone hypoglycaemic effect in rats by

cyclodextrin formulations European Journal of Pharmaceutical Sciences23

2004PP-57-64

74 BDevarakonda et al Comparison of the aqueous solubilization of practically

insoluble niclosamide by polyamidoamine dendrimers and cyclodextrins

International Journal of Pharmaceutics 3042005PP 193-209

75 SHiremath et alImproved dissolution rate of valdecoxib inclusion complexes

with hydroxyl propyl beta cyclodextrinIndian Journal of Pharmaceutical

Sciences692007PP 442-445

76 CHolvoet Development of an omeprazole parenteral formulation with

hydroxypropyl-beta-cyclodextrinPharmaceutical Development and

Technology12(3)2007PP 327-336

77 MChavanpatil et alEnhancement of nasal absorption of acyclovir via

cyclodextrins Journal of Inclusion phenomena and Macrocyclic

Chemistry44(1-4)2002 PP137-140

78 United States Patent 7259153ChangRong-KunDrug formulation and

delivery using crystalline methylated cyclodextrins

79 TLoftsson et al Cyclodextrins in drug delivery Expert opinion Drug

Delivery 2(2) 2005 PP 1-17

80 TLoftsson et al Self association of cyclodextrins and cyclodextrin complexes

Journal of Pharmaceutical Sciences 93(5)2004PP 1091-1099

REFERENCES


81 MEsclusa-Diaz et al Preparation and evaluation of ketoconazole- beta

cyclodextrin multicomponent complexesInternational Journal of

Pharmaceutics1421996PP 183-187

82 K Connors et al The stability of cyclodextrin complexes in solution

Chemical Reviews 97 1997 PP 1325-1357

83 PChaudhari et al solubility enhancement of hydrophobic drugs using

synergistically interacting cyclodextrin and cosolventsCurrent science92(11)

2007PP 1586-1591

84 US patent 545721J Szejtli et al inclusion complexes of taxol or taxotere or

taxus extract formed with cyclodextrins its preparation and use

85 MAl Omari et alComparative study of the inclusion complexation of

pizotifen and ketotifen with native and modified cyclodextrinsJournal of

Solution Chemistry37(2)2008PP 249-264

86 MLinaresSolubilization of naphthaquinones by complexation with

hydroxypropyl β cyclodextrin International Journal of


87 MGuyot Physicochemical characterization and dissolution of norfloxacin-

cyclodextrin inclusion complexes and PEG solid dispersions International

journal of Pharmaceutics1231995PP 53-63

88 TNakate et al Imporvement of pulmonary absorption of cyclopeptide FK 224

in rats by co-formulating with beta cyclodextrin European Journal of

Pharmaceutics and Biopharmaceutics552003PP 147-154

89 HViernstein et alSolubility enhancement of low soluble biologically active

compounds-temperature and cosolvent dependent inclusion

complexationInternational Journal of Pharmaceutics 2562003PP 85-94

REFERENCES


90 T Loftsson et alCyclodextrinsolubilization of benzodiazepinesformulation of

midazolam nasal sprayInternational Journal of Pharmaceutics2122001PP-

29-40

91 K Yap et al Characterization of the 13-Cis-retinoic acidcyclodextrin

inclusion complexes by phase solubility photostability physicochemical and

computational analysis European Journal of pharmaceutical sciences 25

2005PP 49-56

92 P Tayade et al Study of freeze ndashdried quercetin-cyclodextrin binary systems

by DSC X-ray Diffraction and SEM analysis Journal of pharmaceutical and

biomedical analysis34 2004PP 333-339

93 H Archontaki et alStudy on inclusion complexes of bromazepam with beta

and beta hydroxypropylcyclodextrinsJournal of Pharmaceutical and

Biomedical analysis282002PP 761-769

94 O Aleem et al Effect of beta cyclodextrin and hydroxypropyl beta

cyclodextrins complexation on physicochemical properties and antimicrobial

activity of cefdinir Journal of Pharmaceutical and Biomedical analysis 47(3)

2008 PP 535-540

95 S RawatSolubility enhancement of celecoxib using beta cyclodextrin

inclusion complexesEuropean Journal of pharmaceutics and

Biopharmaceutics 57 2004 PP 263-267

96 A Gil et al Evolution of the interaction of a new chemical entity eflucimibe

with gamma cyclodextrin during kneading processEuropean Journal of

Pharmaceutical Sciences 23 2004 PP 123-129

97 HAmmar et al Formulation and biological evaluation of glimepiride-

cyclodextrin-polymer systems International Journal of

Pharmaceutics3092006 PP 129-138

REFERENCES


98 S Rawat et alEnhancement of Industrial absorption of few cox-2 inhibitors

through interaction with β-Cyclodextrins Journal of Pharmaceutical and

Biomedical Analysis 69 (4) 2007 PP529-534

99 H Hassan et al Enhacement of dissolution amount and in vivo bioavailability

of itraconazole by complexation with beta cyclodextrin using supercritical

carbon dioxideJournal of Pharmaceutical and Biomedical

Analysis452007PP 243-250

100 CFernandes et al Physicochemical characterization and in vitro dissolution of

nicardipine-cyclodextrins inclusion compounds European Journal of


101 OSolimann et al Amorphous spironolactone and hydroxypropylated

cyclodextrin complexes with superior dissolution and

bioavailabilityInternational Journal of Pharmaceutics1491997PP73-83

102 Xianhong Wen et al Preparation and study the 12 inclusion complex of

carvedilol with beta cyclodextrin342004PP 517-523

103 KWaleczek et al Phase solubility study of pure (-)-α-bisabolol and camomile

essential oil with β cyclodextrin European Journal of Pharmaceutics and

Biopharmaceutics55(2)2003PP 247-251

104 AAbdoh et alInclusion complexes of diclofenac with natural and modified

cyclodextrins explored through phase solubility1HNMR and molecular

modeling studiesJournal of Inclusion Phenomena and Macrocyclic Chemistry

57(1-4) 2007 PP 503-510

105 Ning Li et alStudy of physicochemical properties of trimethoprim with

cyclodextrin in solution Journal of Pharmaceutical and Biomedical

Analysis382005 PP 370-374

REFERENCES


106 CTimpe et al A novel solvent- based fluidised bed wet granulation process

for solid dispersionAmerical pharmaceutical review Nov2008PP 75-81

107 VYadav et alEnhancement of solubility and dissolution rate of BCS class II

pharmaceuticals by nonaqueous granulation techniqueInternational Journal of

Pharma Research and Development-online12 Feb 2008 PP 1-12

108 YJavadzadeh et alEnhancement of dissolution rate of piroxicam using

liquisolidcompactsII Farmaco602005 PP 361-365

109 YJavadzadeh et alLiquisolid technique as a new approach to sustain

propranolol hydrochloride release from tablet matricesInternational Journal of


110 VYadav et alImprovement of solubility and dissolution of Indomethacin by

liquisolid and compaction granulationJournal of Pharmaceutical Sciences and

Research1(2)2009 PP 44-51

111 IDarwish et alDissolution rate enhancement of gibenclamide using liquisolid

tablet technologyActa Pharmaceutica522002PP 171-179

112 AYadav et alFormulation and evaluation of orodispersibleliquisolid

compacts of aceclofenacIndian Journal of Pharmacy Education and

Research44(3)2010 PP 227-235

113 SSpireas et alIn vitro release evaluation of hydrocortisone liquisolidtablets

Journal of Pharmaceutical Sciences871998 PP 867-872

114 AKarmarkar et alLiquisolid technology for dissolution rate enhancement or

sustaining releaseExpert opinion on drug delivery7(10)2010PP 1227-1234

115 ANokhodchi et al Drug release from liquisolid systems speed it up slow it

down Expert opinion on drug deliveryExpert opinion on drug

delivery8(2)2011PP 191-205

REFERENCES


116 A Karmarkar LiquisolidtabletsA novel approach for drug delivery

International Journal of Health Research 2(1) 2009 PP 45-50

117 K Khaled et al In vivo evaluation of hydrochlorothiazide liquisolid tablets in

beagle dogsInternational Journal of Pharmaceutics 222 2001 PP 1-6

118 SSpirease et alEnhancement of prednisolone dissolution properties using

liquisolidcompacts International Journal of Pharmaceutics1661998PP 177-

188

119 YJavadzadeh et al Liquisolid technique for dissolution rate enhancement of a

high dose water-insoluble drug International Journal of Pharmaceutics 341

2007 PP 26-34

120 S Tayel et al Improvement of dissolution properties of carbamazepine

through application of the liquisolid tablet technique European Journal of

Pharmaceutics and Biopharmaceutics 69 (1) 2008 PP 342-347

121 R Fahmy et al Enhancement of famotidine dissolution rate through liquisolid

tablets formulationin vitro and in vivo evaluation European Journal of


122 BAkinlade et alLiquisolid systems to improve the dissolution of furosemide

Scientia Pharmaceutica 78 2010 PP 325-344

123 SGubbi et al Liquisolid technique for enhancement of dissolution properties

of bromhexinehydrochlorideResearch Journal of Pharmacy and Technology

2 (2) 2009 PP 382-386

124 SGubbi et al Formulation and characterization of atorvastatin calcium

liquisolidcompacts Asian Journal of Pharmaceutical Sciences 5 (2) 2010 PP

50-60

REFERENCES


125 K El-Say et al Formulation and evaluation of rofecoxib liquisolid tablets

International Journal of Pharmaceutical Sciences Review and Research 3 (1)

2010 PP 135-142

126 B El- Houssieny et al Bioavailability and biological activity of liquisolid

compact formula of repaglinide and its effect on glucose tolerance in rabbits

Bioscience Trends 4 (1) 2010 PP 17-24

127 httpwwwaapsjorgabstractsAM_2008AAPS2008-000649PDF

128 N Tiong et al Effects of liquisolid formulations on dissolution of naproxen

European Journal of Pharmaceutics and Biopharmaceutics 73 (3) 2009 PP

373-384

129 Material safety data sheet Tween 20 Cayman Chemical Company 30th

June

2005

130 Santosh Kumar K et al Solubility enhancement of a drug by using liquisolid

technique International Journal of Pharma and biosciences 1(3) 2010 PP 1-5

131 A Kulkarniet al Liquisolid systems A review International Journal of

Pharmaceutical Sciences and Nanotechnology 3 (1) 2010 PP 795-802

132 S Emmadi et al Formulation and pharmacodynamics evaluation of liquisolid

compact Latin American Journal of Pharmacy 29 (8) 2010 PP 1303-1310

133 A Date et al Design and evaluation of self-nanoemulsifying drug delivery

systems (SNEDDS) for cefpodoximeproxetil International Journal of

Pharmaceutics329 (1-2) 2007 PP 166-172

134 Y Ito et alOral solid gentamicin preparation using emulsifier and adsorbent

Journal Of Controlled Release 105 2005 PP 23-31

REFERENCES


135 Shui-Mei Khoo et al Formulation design and bioavailability assessment of

lipidic self-emulsifying formulations of halofantrine Journal of Controlled

Release 105 2005 PP 23-31

136 Y Ito et alPreparation and evaluation of oral solid heparin using emulsifier

and adsorbent for in vitro and in vivo studies International journal of

Pharmaceutics 37 2006 PP 114-119

137 S Shafiq et al Development and bioavailability assessment of ramipril

nanoemulsion formulation European Journal of Pharmaceutics and


138 M Grove et al Bioavailability of seocalcitol IIIAdministration of lipid based

formulations to minipigs in the fasted and fed state European Journal of


139 L Djekic et al The influence of cosurfactants and oils on the formation of

pharmaceutical microemulsions based on PEG-8 capryliccapricglycerides

International Journal of Pharmaceutics 352 2008 PP 231-239

140 P Li et al Effect of combined use of nonionic surfactant on formation of oil-

in-water microemulsions International Journal of Pharmaceutics 288 2005

PP 27-34

141 E Taha et al Preparation and in vitro characterization of self ndashnanoemulsified

drug delivery system (SNEDDS) of all-trans-retinol acetate International

Journal of Pharmaceutics 285 2004 PP 109-119

142 R Sachan et al Selfmicroemulsifying drug delivery system A novel approach

for enhancement of bioavailability International journal of Pharm Tech

Research 2(3) July-Sept 2010 PP 1738-1745

143 ANarang et al Stable drug encapsulation in micelles and microemulsions

International journal of Pharmaceutics 345 2007 PP 9-25

REFERENCES


144 C Goddeeris et al Correlation between digestion of lipid phase of SMEDDS

and release of the anti ndashHIV drg UC 781 and the anti-mycotic drug

enilconazole from SMEDDS European Journal of Pharmaceutics and


145 M Cirri et al Liquid spray formulations of xibornol by using self

microemulsifying drug delivery systems International Journal of


146 PNepal et al Preparation and in vitro-in vivo evaluation of Witepsol H 35

based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme

Q10 European Journal of Pharmaceutical Sciences39 2010 PP 224-232

147 Q Jing et al HPLC determination of anetholetrithione and its application to

the pharmacokinetics in rabbits Journal of Pharmaceutical and Biomedical

Analysis 42 2006 PP 613-617

148 P Postolache et al Cyclosporin bioavailability of two physically different oral

formulations European review for medical and pharmacological sciences 6

2002 PP 127-131

149 B Kang et al Development of self microemulsifying drug delivwry systems

(SMEDDS) for oral bioavailability enhancement of simvastatin in beagle

dogs International Journal of Pharmaceutics 274 (1) 2004 PP 65-73

150 Wei Wu et al Enhanced bioavailability of silymarin by self ndash

microemulsifying drug delivery system European Journal of Pharmaceutics

and Biopharmaceutics63 2006 PP 288-294

151 PZangPreparation and evaluation of self-microemulsifying drug delivery

system of oridonin International Journal of Pharmaceutics 3552008PP 269-

276

REFERENCES


152 Jong Soo Woo Reduced food effect and enhanced bioavailability of a self

microemulsifying formulation of itraconazole in healthy volunteers European

Journal of pharmaceutical sciences 33 2008 PP 159-165

153 MCirri et al Liquid spray formulations of xibornol by using self-


Pharmaceutics 340 (1-2) 2007 PP 84-9

154 RHolm et al Examination of oral absorption and lymphatic transport of

halofantrine in a triple-cannulated canine model after administration in self-

microemulsifying drug delivery systems(SMEDDS) containing structured

triglycerides European Journal of Pharmaceutical Sciences 20 2003 PP 91-

97


lipidic self ndashemulsifying formulations of halofantrine International Journal of


156 APatel et al Preparation and in vivo evaluation of SMEDDS (Self-

Microemulsifying Drug Delivery system) containing finofibrate The AAPS

Journal 9 (3) 2007 Article 41 PP E344-E352

157 SNazzal et al Preparation and in vitro characterization of a eutectic based

semisolid self-nanoemulsified drug delivery system(SNEDDS) of ubiquinone

mechanism and progress of emulsion formation International Journal of


158 Bok Ki Kang et al Controlled release of paclitaxel from microemulsion

containing PLGA and evaluation of anti-tumor activity in vitro and in vivo




REFERENCES


160 I Pasquali et al Supercritical fluid technologiesAn innovative approach for

manipulating the solid ndashstate of pharmaceuticals Advanced Drug Delivery

Reviews 60 2008 PP 399-410

161 F Maulvi et al Supercritical technology A promising approach to enhance

drug solubility Journal of pharmaceutical sciences and research 4 2009 PP

1-14

162 T Yasuji et al Particle design of poorly water soluble drug substances using

supercritical fluid technologies Advanced drug delivery reviews 60 2008 PP

388-398

163 E Reverchon et al Production of micro and nano particles by supercritical

antisolvent precipitation Powder Technology 106 (1-2) 1999 PP 23-29

164 S Wook Jun et al Preparation and characterization of

simvastatinhydroxypropyl beta cyclodextrins inclusion complex using

supercritical Antisolvent(SAS) process European Journal of Pharmaceutics

and biopharmaceutics 66 (3) 2007 PP 413-421

165 H Hassan et al Enhancement of dissolution amount and in vivo

bioavailability of itraconazole by complexation with beta cyclodextrin using

supercritical carbon dioxide Journal of Pharmaceutical and biomedical

analysis (article accessed online)

166 M Kim et al Micronization of cilostazol using supercritical Antisolvent

(SAS) process Effect of process parameters Powder Technology 177 (2)

2007 PP 64-70

167 DWong et al Improved physicochemical characteristics of felodipine solid

dispersionparticles by supercritical anti solvent precipitation process


168 C Kalogiannis et al Production of amoxicillin microparticles by supercritical

antisolvent precipitation Industrial and engineering Chemistry research 44

(24) 2005 PP 9339-9346

REFERENCES


169 I Kikic et al Supercritical antisolvent precipitation of atenolol The influence

of organic solvent and of the processing approach The Journal of Supercritical

Fluids 38 (3) 2006 PP 434-441

170 E Reverchon et al Rifampicine nanoparticles production by supercritical

antisolvent precipitation International Journal of Pharmaceutics 243 (1-2)

2002 PP 83-91

171 CKalogiannis et al Production of amoxicillin microparticles by supercritical

antisolvent precipitation Industrial and Engineering Chemical Research 44

(24) 2005 PP 9339-9346

172 E Reverchon et al Supercritical antisolvent precipitation of cephalosporins

Powder Technology 164 (3) 2006 PP 139-146

173 Y Chang et al Micronization of sulfamethoxazole using supercritical

antisolvent process Journal of Materials Science 43 (7) 2007 PP 2328-2335

174 M Kim et al Preparation characterization and in vivo evaluation of

amorphous atorvastatin calcium nanoparticles using supercritical antisolvent

(SAS) process European Journal of Pharmaceutics and Biopharmaceutics 69

(2) 2008 PP 454-465

175 J Kim et al Physicochemical properties and oral bioavailability of amorphous

atorvastatin hemi-calcium using spray drying and SAS process International

Journal of Pharmaceutics 359 (1-2) 2008 PP 211-219

176 Hee June Park et al Recrystallization of fluconazole using supercritical

antisolvent (SAS) process International Journal of pharmaceutics 328 (2)

2007 PP 152-160

177 I Aranaz Functional characterization of chitin and chitosan Current chemical

Biology 3 2009 PP 203-230

REFERENCES


178 S Dhawan et al Evaluation of mucoadhesive properties of chitosan

microspheres prepared by different methods AAPS Pharm Sci Tech 2004 5

(4) article 67

179 X Shu et al Chitosangelatin microspheres prepared by modified

emulsification and ionotropic gelation Journal of Microencapsulation 18 (2)

2001 PP 237-245

180 Mohanraj et al Nanoparticles reviewTropical Journal of pharmaceutical

Research June 2006 5 (1) PP 561-573

181 Rafeeq et al Development and characterization chitosan nanoparticles loaded

with isoniazide for the treatment of tuberculosis Research Journal of

Pharmaceutical Biological and Chemical sciences Oct ndashDec 2010 PP 383-

390

182 Dustgani et al Preparation of chitosan nanoparticles loaded by dexamethasone

sodium phosphate Iranian Journal of Pharmaceutical SciencesSpring 2008 4

(2) PP 111-114

183 P Saha et al Formulation and evaluation of chitosan based ampicillin

trihydrate nanoparticles Tropical Journal of Pharmaceutical Research 9 (5)

2010 PP 483-488

184 S Jing et al Preparation of influenza vaccinechitosanmicroparticles by ionic

gelation method Chemical Journal of Chinese Universities 29 (11) 2008 PP

2308-2311

185 Lopez-Leon et al Physicochemical characterization of chitosan nanoparticles

electrokinetic and stability behaviour Journal of colloid and interface science

283 (2005) PP 344-351

186 R Rao et al Preparation and characterization of ionotropic chitosan

microparticles for controlled release of aceclofenac International journal of

pharmaceutical sciences and drug research 2010 2 (2) 107-111

REFERENCES


187 SKunjachanUnderstanding the mechanism of ionic gelation for synthesis of

chitosan nanoparticles using qualitative techniques Asian Journal of


188 RPignatello et al Ocular Tolerability of Eudragit RS 100 and RL 100

nanosuspensions as carriers for ophthalmic controlled drug delivery Journal

of Pharmaceutical sciences 91 (12) 2002 PP 2636-2641

189 RPignatello et al Eudragit RS 100 nanosuspensions for ophthalmic controlled

delivery of ibuprofen European Journal Of Pharmaceutical Sciences16(1-2)

2002 PP 53-61

190 wwweudragitevonikcom

191 CDora et al Development and characterization of nanoparticles of

glibenclamide by solvent displacement method Acta Poloniae Pharmaceutica

67 (3) 2010 PP 283-290

192 SMudgal et al Design and development of 5-flurouracil loaded biodegradable

microspheres International Journal of Research in Ayurveda and Pharmacy 1

(1) 2010 PP 160-168

193 PDevrajan et al Preparation and in vitroin vivo evaluation of gliclazide

loaded eudragit nanoparticles as sustained release carriers Drug Development

and industrial Pharmacy 33 (2) 2007 PP 101-111

194 httpwwwpharmagatewaynetSearchAdvancedaspxq=Eudragit20L-100

195 H Eerikainen et al Preparation of polymeric nanoparticles containing

corticosteroid by a novel aerosol flow reactor method International Journal of



polymer nanoparticles Reviews on Advanced Materials Science 17 2008 PP

71-75

REFERENCES


197 M Gupta et al Nanoparticulate drug delivery system of cyclosporine

International Journal of Pharmacy and pharmaceutical Sciences 1 (2) 2009

PP 81-92

198 H Stenhoff et al Determination of candesartan cilexetilcandesartan and a

metabolite in human plasma and urine by liquid chromatography and

fluorometricdetection Journal of Chromatography BBiomedical Sciences and

Applications 731 (2) 1999 PP 411-417

199 M Levi et al Direct analysis of valsartan or candesartan in human plasma and

urines by on-line solid phase extraction coupled to electrospray tandem mass

spectrometry Journal of Chromatography B 877 (10) 2009 PP 919-926

200 APeepliwal et al Bioanalytical method development and its validation for

determination of candesartan cilexetil by high performance liquid

chromatography with UV detection ActaPharmaceutica Sciencia 52 2010

PP 247-253

201 N Erk Simultaneous analysis of candesartan cilexetil and hydrochlorothiazide

in human plasma and dosage forms using HPLC with a photodiode array

detector Journal of Liquid Chromatography and Related Technologies 26

(15) 2003 PP 2581-2591

202 A Sakur et al Determination of candesartan cilexetil in tablets by

spectrofluorimetry International Journal of Pharmaceutical Sciences Review

and Research 4 (1) 2010 PP 60-63

203 S Mehta et al LC and LC-MSTOF studies on stress degradation behavior of

candesartan cilexetil Journal of Pharmaceutical and Biomedical Analysis 52

(3) 2010 PP345-354

REFERENCES


1 Y Kwon Handbook of essential pharmacokinetics pharmacodynamics and

drug metabolism for industrial scientists 2001 Springer publication New

York PP 35-45

2 L Edwards et al Principle and practice of pharmaceutical medicines 2 nd

edition2007 Wiley publication PP 85

3 W Foye et al Foyersquos Principles of medicinal chemistry sixth edition2007

Lippincott publication PP 300

4 C Ehrhardt et al Drug absorption studies in situ in vitro and in silico models

illustrated edition AAPS Press Springer publication 2008 PP 666

5 Y Qiu et al Developing solid oral dosage formspharmaceutical theory and

practice first edition 2009 Elsvier Publication USA PP 421-436

6 A Avdeef Absorption and drug development solubilitypermeability and

charge state John Wiley and sons Wiley interscience publication 2003 PP

20

7 Waiver of in vivo bioavailability and bioequivalence studies for immediate

release solid oral dosage forms based on a biopharmaceutics classification

system Guidance for industry USFDACDER Aug 2000

8 httpenwikipediaorgwikiBioavailability

9 Wagh et al Biopharmaceutical classification system International journal of

pharmacy and pharmaceutical sciences 2(1) 2010 PP 12-19

10 Banker and Rhodes Modern pharmaceutics 121 fourth edition Marcel

Dekker PP 84-86

11 Brahmankar and Jaiswal et al Biopharmaceutics and pharmacokinetics- a

treatise first edition Vallabh prakashan Delhi PP 18

REFERENCES









155ndash157







948ndash951





303






REFERENCES




1193ndash1197










68









149ndash174




REFERENCES




2003 PP 113ndash120



2002 PP 1ndash13














PP 23ndash29



235ndash244




REFERENCES




271 (1ndash2) 2004 PP 145ndash154










Pharmacy 32(5) 2006 PP 559-567



242 (1-2) 2002 PP 3-14



PP 38-42



71-75






REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES









155ndash157







948ndash951





303






REFERENCES




1193ndash1197










68









149ndash174




REFERENCES




2003 PP 113ndash120



2002 PP 1ndash13














PP 23ndash29



235ndash244




REFERENCES




271 (1ndash2) 2004 PP 145ndash154










Pharmacy 32(5) 2006 PP 559-567



242 (1-2) 2002 PP 3-14



PP 38-42



71-75






REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




1193ndash1197










68









149ndash174




REFERENCES




2003 PP 113ndash120



2002 PP 1ndash13














PP 23ndash29



235ndash244




REFERENCES




271 (1ndash2) 2004 PP 145ndash154










Pharmacy 32(5) 2006 PP 559-567



242 (1-2) 2002 PP 3-14



PP 38-42



71-75






REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




2003 PP 113ndash120



2002 PP 1ndash13














PP 23ndash29



235ndash244




REFERENCES




271 (1ndash2) 2004 PP 145ndash154










Pharmacy 32(5) 2006 PP 559-567



242 (1-2) 2002 PP 3-14



PP 38-42



71-75






REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




271 (1ndash2) 2004 PP 145ndash154










Pharmacy 32(5) 2006 PP 559-567



242 (1-2) 2002 PP 3-14



PP 38-42



71-75






REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES





1998 PP 11ndash19













edition 2009








Bulletine 47(2) 1999 PP 182-186


REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES



60 httpwwwsciruscom














1017-1025





chemistry 76(10)2004 PP 1825-1845





REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES







2005PP 487-492



2004PP-57-64












Chemistry44(1-4)2002 PP137-140




Delivery 2(2) 2005 PP 1-17



REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES









2007PP 1586-1591


















REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




29-40




2005PP 49-56










2008 PP 535-540










REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES























57(1-4) 2007 PP 503-510




REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES



















Research44(3)2010 PP 227-235







delivery8(2)2011PP 191-205

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES








188



2007 PP 26-34











2 (2) 2009 PP 382-386



50-60

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




2010 PP 135-142







373-384


June

2005












REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




Release 105 2005 PP 23-31















PP 27-34









REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES














Analysis 42 2006 PP 613-617



2002 PP 127-131









276

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES












97
















REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




Reviews 60 2008 PP 399-410



1-14



388-398













2007 PP 64-70






(24) 2005 PP 9339-9346

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




Fluids 38 (3) 2006 PP 434-441



2002 PP 83-91



(24) 2005 PP 9339-9346








(2) 2008 PP 454-465






2007 PP 152-160


Biology 3 2009 PP 203-230

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




(4) article 67



2001 PP 237-245






390



(2) PP 111-114



2010 PP 483-488



2308-2311



283 (2005) PP 344-351




REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES










2002 PP 53-61




67 (3) 2010 PP 283-290



(1) 2010 PP 160-168










71-75

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

REFERENCES




PP 81-92




Applications 731 (2) 1999 PP 411-417







PP 247-253




(15) 2003 PP 2581-2591






(3) 2010 PP345-354

14_references 8.pdf - shodhganga

Documents